Literature DB >> 14671051

Increased hydrogen peroxide in the exhaled breath of uraemic patients unaffected by haemodialysis.

Jacek Rysz1, Marek Kasielski, Joanna Apanasiewicz, Maciej Król, Andrzej Woźnicki, Marek Luciak, Dariusz Nowak.   

Abstract

BACKGROUND: Uraemia is accompanied by conditions favouring the rise of H2O2 activity in body fluids. This results from the increased release of H2O2 by polymorphonuclear leukocytes and decreased plasma glutathione peroxidase activity. The purpose of this study was to determine if patients on chronic haemodialysis (HD) exhale more H2O2 than healthy individuals, and if dialysis affects breath H2O2 content.
METHODS: We studied 29 chronic HD patients (mean age 49 +/- 11 years) and 40 healthy persons (mean age 44 +/- 9 years). H2O2, which is volatile, was measured fluorimetrically with the homovanillic acid method in the exhaled breath condensate (EBC) of the study cohort. EBC was collected immediately before and after the HD session and also at 20 and 60 min of HD treatment (n = 14) and once in controls. Peak expiratory flow (PEF), white blood cell (WBC) count, PaO(2) and circulatory cyclic guanosine monophosphate (cGMP), Il-6 and Il-8 concentrations were measured concomitantly. Finally, H2O2 diffusion through the dialyser cuprophane membrane was determined in an in vitro experiment.
RESULTS: At baseline, EBC H2O2 concentration was 22 times higher in HD patients than in controls (2.92 +/- 4.64 vs 0.16 +/- 0.13 microM, P < 0.001). Although the maximum decrease in PEF (431 +/- 52 vs 398 +/- 56 l/min, P < 0.01) and WBC count (6.72 +/- 1.02 vs 3.82 +/- 1.51 x 10(3)/ microl, P < 0.01) occurred at 20 min after the start of HD, no significant changes in breath H2O2 levels were noted throughout the session. Plasma IL-6 and IL-8 levels remained unchanged whereas cGMP rose 1.3 times at 60 min (P < 0.01). In vitro, H2O2 rapidly diffused through the cuprophane membrane.
CONCLUSION: Chronic HD patients exhale more H2O2 than healthy subjects. Although no change of breath H2O2 concentration was observed during HD, as H2O2 easily diffuses through the dialyser membrane, it is not possible to rule out that HD stimulates H2O2 generation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14671051     DOI: 10.1093/ndt/gfg499

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

1.  Oxidative stress, superoxide production, and apoptosis of neutrophils in dogs with chronic kidney disease.

Authors:  Adriana Carolina Rodrigues Almeida Silva; Breno Fernando Martins de Almeida; Carolina Soares Soeiro; Wagner Luis Ferreira; Valéria Marçal Félix de Lima; Paulo César Ciarlini
Journal:  Can J Vet Res       Date:  2013-04       Impact factor: 1.310

2.  Feline obesity causes hematological and biochemical changes and oxidative stress - a pilot study.

Authors:  Tainara de Oliveira Martins; Rebecca Cápera Ramos; Geovana Possidonio; Maria Rachel Melo Bosculo; Paula Lima Oliveira; Leticia Ramos Costa; Vinicius Aquiles Gomes Zamboni; Marcel Gambin Marques; Breno Fernando Martins de Almeida
Journal:  Vet Res Commun       Date:  2022-07-02       Impact factor: 2.459

3.  Increased H2O2 level in exhaled breath condensate in primary breast cancer patients.

Authors:  Robert A Stolarek; Elzbieta Potargowicz; Ewa Seklewska; Jarosław Jakubik; Marek Lewandowski; Arkadiusz Jeziorski; Dariusz Nowak
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-05       Impact factor: 4.553

Review 4.  Exhaled Breath Condensate: Technical and Diagnostic Aspects.

Authors:  Efstathia M Konstantinidi; Andreas S Lappas; Anna S Tzortzi; Panagiotis K Behrakis
Journal:  ScientificWorldJournal       Date:  2015-05-27

5.  Serum Myo-Inositol, Dimethyl Sulfone, and Valine in Combination with Creatinine Allow Accurate Assessment of Renal Insufficiency-A Proof of Concept.

Authors:  Jochen Ehrich; Laurence Dubourg; Sverker Hansson; Lars Pape; Tobias Steinle; Jana Fruth; Sebastian Höckner; Eric Schiffer
Journal:  Diagnostics (Basel)       Date:  2021-02-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.